Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia

Minerva Anestesiologica

Volumn 77, Issue 10, 2011, Pages 964-970

  Giantsou, E ^a   Manolas, K I ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Pneumonia; Pseudomonas aeruginosa; Superinfection

Indexed keywords

AMIKACIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL SUPERINFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL PULMONARY INFECTION SCORE; CONTROLLED STUDY; FOLLOW UP; HUMAN; INCIDENCE; LUNG LAVAGE; MAJOR CLINICAL STUDY; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PHENOTYPE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; SCORING SYSTEM; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; APACHE; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; RESEARCH DESIGN; SUPERINFECTION; TREATMENT OUTCOME;

EID: 80053436759     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wunderink RG. Ventilator-associated pneumonia. Failure to respond to antibiotic therapy. Clin Chest Med 1995;16:173-93.
2. Chastre J, Fagon JY. State of the art. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
3. Rello J, Quintana E, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of nosokomial pneumonia in mechanically ventilated patients. Chest 1991;100:439-44.
4. Eagye K, Nicolau DP, Kuti JL. Impact of superinfection on hospital length of sty and costs in patients with ventilator- associated pneumonia. Semin Respir Crit Care Med 2009;30:116-24.
5. Montravers P, Fagon JY, Chastre J, Lesco M, Dombret MC, Trouillet JL et al. Follow-up protected specimen brushes to assess treatment in nosockomial pneumonia. Am J Respir Crit Care Med 1993;147:38-44.
6. Fox RC, Williams GJ, Wunderink RG. Follow-up bronchoscopy predicts therapeutic outcomes in ventilated patients with nosokomial pneumonia. Am Rev Respir Dis 1991;143:109.
7. Vidaur L, Planas K, Sierra R, Dimopoulos G, Ramirez A, Lisboa T et al. Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resource utilization. Chest 2008;133:625-32.
8. American Thoracic Society. Infectious Diseases Society of America: guidelines for the management of adults with hospital acquired, ventilator-associated and healthcare associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
9. Langer M, Haeusler EA. Ventilator-associated pneumonia (VAP): an impossible diagnosis? Call for a pragmatic approach. Minerva Anestesiol 2009;75:584-90.
10. Giantsou E, Liratzopoulos N, Efraimidou E, Maria Panopoulou, Eleonora Alepopoulou, Sofia Kartali-Ktenidou et al. Both early-onset and late-onset ventilator-associated pneumonia are mainly caused by potentially multiresistant bacteria. Intensive Care Med 2005;31:1488-94.
11. Bearsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution specific guidelines for the treatment of hospital acquired pneumonia. Chest 2006;130:787-93.
12. Lampati L, Maggioni E, Langer M, Malacarne P, Mozzo R, Pesenti A et al. Can routine surveillance samples from tracheal aspirate predict bacterial flora in cases of ventilator-associated pneumonia? Minerva Anestesiol 2009;75:555-62.
13. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH et al. Interpreting chromosomal DNA restriction fragments produced by pulsed field gel electrophoresis. Criteria for bacterial strain typing. Clin Microbiol 1995:33:2233-9.
14. Wassenaar TM. Molecular typing of pathogens. Berl Munch Tierarztl Wochenschr 2003:116:447-53.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score based on a European /North American Study. JAMA 1993;270:2957-63.
16. Vincent JL, Moreno R, Takala J, Willatts S, De Mendoca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22;707-10.
17. Luna LM, Blanzaco M, Daniel D, Niederman MS, Matarucco W, Baredes NC et al. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome Crit Care Med 2003;31:676-82.
18. Schentag JJ, Reitberg DP, Cumbo TJ. Cefmenoxime effito cacy, safety and pharmacokinetics in critical care patients with nosokomial pneumonia. Am J Med 1984;77:34-42.
19. Klasterky J, Carpentier-Meunier F, Kahan-Coppens L, Thys JP. Endotracheally administered antibiotics for Gram negative bronchopneumonia. Chest 1979;75:586-91.
20. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 2003;290:2588-98.
21. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med 2006;32:1970-8.
22. Raymond DP, Pelletier SJ, Crabtree TD, Evans HL, Pruett TL, Sawyer RG. Impact of antibiotic resistant Gram negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003;31:1035-41.
23. Spanik S, Krupova I, Trupl J, Kunova A, Novothy J, Mateicka F et al. Bacteremia due to multiresistant Gram Negative bacilli in neutropenic cancer patients: a case controlled study. J infect Chemother 1999;5:180-4.
24. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosokomial bacteremia caused by antibiotic resistant Gram negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600-6.